Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations

Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations

Abstract Background Hyperglycaemia may contribute to failure to recover from pulmonary exacerbations in cystic fibrosis (CF). We aimed to evaluate the prevalence and mechanism of hyperglycaemia during and post‐exacerbations. Methods Nine paediatric CF patients, not on insulin, hospitalized for intra...

Full description

Bibliographic Details
Main Authors:	Lina Merjaneh, Demet Toprak, Sharon McNamara, Laura Nay, Erin Sullivan, Margaret Rosenfeld
Format:	Article
Language:	English
Published:	Wiley 2021-04-01
Series:	Endocrinology, Diabetes & Metabolism
Subjects:	continuous glucose monitoring cystic fibrosis‐related diabetes hyperglycaemia insulin oral glucose tolerance test
Online Access:	https://doi.org/10.1002/edm2.208

Similar Items

Fucoidan from sea cucumber protects against high-fat high-sucrose diet-induced hyperglycaemia and insulin resistance in mice
by: Shiwei Hu, et al.
Published: (2014-09-01)

Distribution of OGTT-Related Variables in Patients with Cystic Fibrosis from Puberty to Adulthood: An Italian Multicenter Study
by: Andrea Foppiani, et al.
Published: (2023-03-01)

The effect of cystic fibrosis transmembrane conductance regulator modulators on impaired glucose tolerance and cystic fibrosis related diabetes
by: Sana Hasan, et al.
Published: (2022-09-01)

Prepuberal insulin secretory indices are long-term predictors of short adult stature in cystic fibrosis
by: Alberto Battezzati, et al.
Published: (2022-05-01)

Quality of dietary macronutrients is associated with glycemic outcomes in adults with cystic fibrosis
by: Tanicia C. Daley, et al.
Published: (2023-09-01)

Spontaneous and iatrogenic hypoglycemia in cystic fibrosis
by: Rebecca Hicks, et al.
Published: (2021-12-01)

Oral Glucose Tolerance Testing Using Candy: A Sweet Solution to Improve Screening in Children with Cystic Fibrosis?
by: Caroline Weeks, et al.
Published: (2023-07-01)

Hyperglycaemia in the Newborn Infant. Physiology Verses Pathology
by: Kathryn Beardsall, et al.
Published: (2021-07-01)

A review of stress-induced hyperglycaemia in the context of acute ischaemic stroke: Definition, underlying mechanisms, and the status of insulin therapy
by: Mengyue Yao, et al.
Published: (2023-03-01)

Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
by: N Waugh, et al.
Published: (2010-09-01)

Screening Methods for Diagnosing Cystic Fibrosis-Related Diabetes: A Network Meta-Analysis of Diagnostic Accuracy Studies
by: Vera Dóra Izsák, et al.
Published: (2021-03-01)

Screening for cystic fibrosis-related diabetes: a systematic review
by: N Waugh, et al.
Published: (2012-05-01)

Cystic Fibrosis-Related Diabetes (CFRD): Overview of Associated Genetic Factors
by: Fernanda Iafusco, et al.
Published: (2021-03-01)

Enrichment of sulphate-reducers and depletion of butyrate-producers may be hyperglycaemia signatures in the diabetic oral microbiome
by: Camilla Pedrosa Vieira Lima, et al.
Published: (2022-12-01)

Characterization of glucose metabolism in youth with vs. without cystic fibrosis liver disease: A pilot study
by: Maria Socorro Rayas, et al.
Published: (2022-06-01)

Use of continuous glucose monitoring in diagnosis and management of cystic fibrosis-related diabetes in children
by: Sze M Ng, et al.
Published: (2020-01-01)

Impact of admission and early persistent stress hyperglycaemia on clinical outcomes in acute pancreatitis
by: Xinmin Yang, et al.
Published: (2022-10-01)

Hyperglycaemia increases mortality risk in non‐diabetic patients with COVID‐19 even more than in diabetic patients
by: Jennifer Morse, et al.
Published: (2021-10-01)

Comparison of continuous glucose monitoring to reference standard oral glucose tolerance test for the detection of dysglycemia in cystic Fibrosis: A systematic review
by: Shanal Kumar, et al.
Published: (2022-12-01)

Prevalence, Predictors and Prognosis of Post-Stroke Hyperglycaemia in Acute Stroke Trials: Individual Patient Data Pooled Analysis from the Virtual International Stroke Trials Archive (VISTA)
by: Keith W. Muir, et al.
Published: (2011-03-01)

Carbohydrates – Guidelines on Parenteral Nutrition, Chapter 5
by: Working group for developing the guidelines for parenteral nutrition of The German Association for Nutritional Medicine, et al.
Published: (2009-11-01)

Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF
by: Kevin J. Scully, et al.
Published: (2024-02-01)

Dietary interventions for managing glucose abnormalities in cystic fibrosis: a systematic review protocol
by: Laura Birch, et al.
Published: (2018-07-01)

Managing hyperglycaemia in hospitalized patients
by: Uditha Bulugahapitiya
Published: (2012-10-01)

Oral Glucose Tolerance Test in Patients with Cystic Fibrosis Compared to the Overweight and Obese: A Different Approach in Understanding the Results
by: Mirela Mogoi, et al.
Published: (2022-04-01)

Clinical practice versus guidelines for the screening of cystic fibrosis-related diabetes: A French survey from the 47 centers
by: Laurence Weiss, et al.
Published: (2022-06-01)

Defects of secretion in cystic fibrosis /
by: Schultz, Carsten
Published: (2005)

Vertical transmission of the gut microbiota influences glucose metabolism in offspring of mice with hyperglycaemia in pregnancy
by: Cunxi Xue, et al.
Published: (2022-08-01)

Hyperglycaemia and Its Prognostic Value in Patients with COVID-19 Admitted to the Hospital in Lithuania
by: Lina Zabuliene, et al.
Published: (2023-12-01)

A provider survey of cystic fibrosis related diabetes screening and management practices at North American CF centers
by: Rebecca Hicks, et al.
Published: (2023-05-01)

Glucocorticoid induced hyperglycaemia
by: M I Weerakkody, et al.
Published: (2012-05-01)

Short-Term Effects of Elexacaftor/Tezacaftor/Ivacaftor Combination on Glucose Tolerance in Young People With Cystic Fibrosis—An Observational Pilot Study
by: Insa Korten, et al.
Published: (2022-04-01)

Impact of admission hyperglycaemia on clinical outcomes in non‐diabetic heart failure with preserved ejection fraction
by: Masamichi Yano, et al.
Published: (2021-10-01)

A Single-Dose of a Polyphenol-Rich Fucus Vesiculosus Extract is Insufficient to Blunt the Elevated Postprandial Blood Glucose Responses Exhibited by Healthy Adults in the Evening: A Randomised Crossover Trial
by: Margaret Murray, et al.
Published: (2019-02-01)

Eating disorders and body image in cystic fibrosis
by: Amy Darukhanavala, et al.
Published: (2021-12-01)

Cystic fibrosis related liver disease and endocrine considerations
by: Jordan S. Sherwood, et al.
Published: (2022-03-01)

A randomised controlled trial to compare minimally invasive glucose monitoring devices with conventional monitoring in the management of insulin-treated diabetes mellitus (MITRE)
by: SP Newman, et al.
Published: (2009-05-01)

Economic evaluation of type 2 diabetes prevention programmes: Markov model of low- and high-intensity lifestyle programmes and metformin in participants with different categories of intermediate hyperglycaemia
by: Samantha Roberts, et al.
Published: (2018-01-01)

Cystic fibrosis-related diabetes: Prevalence, screening, and diagnosis
by: Swapnil Khare, et al.
Published: (2022-03-01)

Significance of fructosamine in the diagnosis of carbohydrate metabolism disorders in children with cystic fibrosis
by: N. V. Liabina, et al.
Published: (2022-03-01)